CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T Syst-...
Phase 2
Indianapolis, Indiana, United States and 23 other locations
This open-label, non-randomized Phase II trial is designed to assess the safety and tolerability of GT103 in combination with pembrolizumab ...
Phase 2
Indianapolis, Indiana, United States and 5 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Indianapolis, Indiana, United States and 283 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Indianapolis, Indiana, United States and 262 other locations
This study is an open label, multicenter, randomized phase II trial of consolidation immunotherapy with either nivolumab alone or the combination of...
Phase 2
Indianapolis, Indiana, United States and 11 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Indianapolis, Indiana, United States and 206 other locations
The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy ...
Phase 3
Indianapolis, Indiana, United States and 252 other locations
observation following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) wit...
Phase 2
Indianapolis, Indiana, United States and 12 other locations
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non...
Phase 2
Indianapolis, Indiana, United States and 221 other locations
and platinum-based chemotherapy for patients with advanced non-small cell lung cancer that has spread to...
Phase 3
Indianapolis, Indiana, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal